171 related articles for article (PubMed ID: 33848645)
1. Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.
Yang Q; Zhou Q; He X; Cai J; Sun S; Huang B; Wang Z
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102145. PubMed ID: 33848645
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
[TBL] [Abstract][Full Text] [Related]
3. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?
Lee SH; Cho KJ; Ko MH; Cho HY; Lee KB; Lim S
Obstet Gynecol Sci; 2018 Jan; 61(1):88-94. PubMed ID: 29372154
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA-IIA Cervical Cancer.
Cao L; Kong W; Li J; Song D; Jin B; Liu T; Han C
Gynecol Obstet Invest; 2023; 88(1):30-36. PubMed ID: 36450266
[TBL] [Abstract][Full Text] [Related]
6. Parametrial involvement in women with low-risk, early-stage cervical cancer.
Vanichtantikul A; Tantbirojn P; Manchana T
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
[TBL] [Abstract][Full Text] [Related]
7. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P
Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714
[TBL] [Abstract][Full Text] [Related]
8. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
9. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.
Frumovitz M; Sun CC; Schmeler KM; Deavers MT; Dos Reis R; Levenback CF; Ramirez PT
Obstet Gynecol; 2009 Jul; 114(1):93-99. PubMed ID: 19546764
[TBL] [Abstract][Full Text] [Related]
10. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer.
Boyraz G; Basaran D; Salman MC; Ozgul N; Yuce K
Ginekol Pol; 2016; 87(6):417-21. PubMed ID: 27418217
[TBL] [Abstract][Full Text] [Related]
12. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
[TBL] [Abstract][Full Text] [Related]
13. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
14. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of retroperitoneal lymph node involvement in clinical stage IB and IIA cervical cancer.
Erdem B; Çelebi İ; Aşıcıoğlu O; Akgöl S; Yüksel İT; Özaydin İY; Topbaş F; Akbayir Ö
J Cancer Res Ther; 2022; 18(6):1548-1552. PubMed ID: 36412408
[TBL] [Abstract][Full Text] [Related]
16. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
Hsu HC; Tai YJ; Chen YL; Chiang YC; Chen CA; Cheng WF
PLoS One; 2018; 13(10):e0204950. PubMed ID: 30335786
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
19. Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?
Rakowski JA; Tran TA; Ahmad S; James JA; Brudie LA; Pernicone PJ; Radi MJ; Holloway RW
Gynecol Oncol; 2012 Oct; 127(1):98-101. PubMed ID: 22800652
[TBL] [Abstract][Full Text] [Related]
20. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
